NextEvo, Inc.

Amendment
CIK: 0002053885·Pharmaceuticals·DELAWARE·Filed: Apr 29, 2026
Total Offering

Indefinite

Amount Sold

$725,000

Investors

1

First Sale

Jan 13, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Howard Goodwin
Gerry McNally
Cornelius Merlini
Gerald Stahlecker
Ross Desmarais

Company

NextEvo, Inc.

181 WASHINGTON STREET

CONSHOHOCKEN, PA, 19428

925-200-6766

SEC Filing

0002053885-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
NextEvo, Inc. Form D Filing — Indefinite | FilingFlow